KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Guardant Health (GH) over the last 6 years, with Sep 2025 value amounting to $124.8 million.

  • Guardant Health's Shares Outstanding (Diluted Average) rose 1.43% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.8 million, marking a year-over-year increase of 1.43%. This contributed to the annual value of $122.7 million for FY2024, which is 9.61% up from last year.
  • Guardant Health's Shares Outstanding (Diluted Average) amounted to $124.8 million in Q3 2025, which was up 0.56% from $124.1 million recorded in Q2 2025.
  • Guardant Health's 5-year Shares Outstanding (Diluted Average) high stood at $124.8 million for Q3 2025, and its period low was $101.0 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $118.5 million, with a median of $122.4 million in 2024.
  • Data for Guardant Health's Shares Outstanding (Diluted Average) shows a peak YoY climbed of 18.55% (in 2024) over the last 5 years.
  • Guardant Health's Shares Outstanding (Diluted Average) (Quarterly) stood at $101.3 million in 2021, then rose by 0.85% to $102.2 million in 2022, then rose by 9.60% to $112.0 million in 2023, then increased by 9.61% to $122.7 million in 2024, then climbed by 1.43% to $124.8 million in 2025.
  • Its last three reported values are $124.8 million in Q3 2025, $124.1 million for Q2 2025, and $123.9 million during Q1 2025.